Syntal Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,545	Closed	-$1.71M	–	119
2022 Q1	$1.71M	Buy	+6,545	New	+$1.71M	0.67%	35
2020 Q3	–	Sell	-4,628	Closed	-$1.34M	–	126
2020 Q2	$1.34M	Buy	+4,628	New	+$1.34M	0.63%	50